Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac Sells 4,583 Shares of Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 4,583 shares of the business’s stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $7.24, for a total transaction of $33,180.92. Following the completion of the sale, the chief executive officer now owns 310,758 shares of the company’s stock, valued at $2,249,887.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

K Charles Janac also recently made the following trade(s):

  • On Wednesday, July 3rd, K Charles Janac sold 9,168 shares of Arteris stock. The shares were sold at an average price of $7.23, for a total transaction of $66,284.64.
  • On Tuesday, June 4th, K Charles Janac sold 3,303 shares of Arteris stock. The stock was sold at an average price of $7.70, for a total value of $25,433.10.

Arteris Stock Performance

Shares of AIP stock opened at $7.21 on Thursday. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.24 and a quick ratio of 1.24. The company’s fifty day simple moving average is $7.82 and its 200-day simple moving average is $6.95. Arteris, Inc. has a 52 week low of $4.20 and a 52 week high of $9.54.

Arteris (NASDAQ:AIPGet Free Report) last released its quarterly earnings data on Thursday, May 2nd. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. The company had revenue of $12.95 million for the quarter, compared to analyst estimates of $12.60 million. Arteris had a negative return on equity of 198.35% and a negative net margin of 69.70%. On average, equities research analysts expect that Arteris, Inc. will post -0.91 earnings per share for the current year.

Analysts Set New Price Targets

AIP has been the topic of a number of research analyst reports. Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 target price on shares of Arteris in a report on Friday, May 3rd. Jefferies Financial Group restated a “hold” rating and issued a $9.00 price objective (down from $11.00) on shares of Arteris in a report on Monday, May 13th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Arteris currently has a consensus rating of “Moderate Buy” and a consensus price target of $13.40.

Check Out Our Latest Stock Analysis on AIP

Institutional Investors Weigh In On Arteris

Several hedge funds have recently modified their holdings of AIP. Victory Capital Management Inc. acquired a new stake in Arteris in the fourth quarter valued at approximately $60,000. Algert Global LLC purchased a new position in shares of Arteris in the third quarter valued at $142,000. Worth Venture Partners LLC grew its holdings in Arteris by 22.6% during the 3rd quarter. Worth Venture Partners LLC now owns 51,301 shares of the company’s stock valued at $334,000 after purchasing an additional 9,448 shares in the last quarter. Citigroup Inc. purchased a new stake in Arteris during the 3rd quarter worth $363,000. Finally, Federated Hermes Inc. lifted its holdings in Arteris by 8.3% in the 3rd quarter. Federated Hermes Inc. now owns 130,000 shares of the company’s stock worth $846,000 after buying an additional 10,000 shares in the last quarter. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Further Reading

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.